Similar articles

• Genomics, personalized medicine and cancer practice.

  Dancey J. Dancey J. Clin Biochem. 2012 Apr;45(6):379-81. doi: 10.1016/j.clinbiochem.2012.03.003. Clin Biochem. 2012. PMID: 22424082 No abstract available.
• International Cancer Conference: targeted therapies boom expected in 3-5 years.

  Gethins M. Gethins M. J Natl Cancer Inst. 2011 Oct 19;103(20):1491-3. doi: 10.1093/jnci/djr414. Epub 2011 Oct 4. J Natl Cancer Inst. 2011. PMID: 21972228 No abstract available.
• The search for optimal response prediction in cancer leads to a personalized approach.

  Van Cutsem E, Ciardiello F. Van Cutsem E, et al. Target Oncol. 2010 Mar;5(1):3-4. doi: 10.1007/s11523-010-0139-4. Epub 2010 Mar 28. Target Oncol. 2010. PMID: 20349283 No abstract available.
• The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.

  Cloonan N, Waddell N, Grimmond SM. Cloonan N, et al. IDrugs. 2010 Nov;13(11):778-81. IDrugs. 2010. PMID: 21046525 Review.
• MiRNAs as biomarkers and therapeutic targets in cancer.

  Heneghan HM, Miller N, Kerin MJ. Heneghan HM, et al. Curr Opin Pharmacol. 2010 Oct;10(5):543-50. doi: 10.1016/j.coph.2010.05.010. Epub 2010 Jun 10. Curr Opin Pharmacol. 2010. PMID: 20541466 Review.